SOX4 and non-small cell lung carcinoma: Additionally, upregulating miR-656-3p might improve the chemotherapeutic efficacy in NSCLC by target-regulating sex-determining region Y-related high-mobility group box 4 (SOX4) (Wang et al., 2020).